Merck (MRK) ended the recent trading session at $86.32, demonstrating a +1.8% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 1.07%. On the ...

Summit Therapeutics shares Phase 3 data showing ivonescimab cut cancer progression risk by 40% and plans BLA submission in ...

Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with ...

Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...

The U. Congressional Budget Office said on Monday that new exemptions to drug price negotiations for several blockbuster cancer medicines under President Trump's One Big Beautiful Bill Act will cost ...

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...

Jamie Dimon is one of the highest-profile bankers in the world. Like Warren Buffett, David Solomon, or other Wall Street ...

These Goldman Sachs stock picks are poised for growth in 2026 and will continue to pay and raise their significant and ...

AbbVie ABBV has built a substantial oncology franchise in recent years. Initially anchored by blood cancer drugs Imbruvica ...

The post Market Analysis: Oct 20th, 2025 appeared first on Stock Target Advisor.

US stocks rose strongly on Monday, closing in on record highs reached earlier this month, on the back of improving sentiment ...

Yahoo Finance is chronicling the latest news and updates on President Trump's plans to impose tariffs on goods from other ...